BioNexus Gene Lab (BGLC) Gains from Investment Securities (2018 - 2025)
BioNexus Gene Lab recorded quarterly Gains from Investment Securities of -$154.0 in Q4 2025, up 92.85% quarter-over-quarter from -$2155.0 in Q3 2025, and down 102.35% year-over-year from $6562.0 in Q4 2024.
BioNexus Gene Lab's Gains from Investment Securities history runs 7 years deep, the most recent figure standing at -$154.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities fell 102.35% year-over-year to -$154.0; the TTM figure through Mar 2026 stood at -$9899.0 (down 101.97% YoY), while the FY2025 annual figure was -$14823.0, down 103.01% from the prior year.
- Gains from Investment Securities came in at -$154.0 for Q4 2025 at BioNexus Gene Lab, up from -$2155.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $610213.0 in Q4 2021 to a low of -$251776.0 in Q2 2021.
- A 5-year average of $39806.8 and a median of -$7590.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities slumped 2146.35% in 2021 and jumped 3086.91% in 2024, its largest moves.
- BioNexus Gene Lab's Gains from Investment Securities stood at $610213.0 in 2021, then sank by 127.64% to -$168649.0 in 2022, then jumped by 88.64% to -$19165.0 in 2023, then soared by 134.24% to $6562.0 in 2024, then sank by 102.35% to -$154.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$154.0, -$2155.0, and -$7590.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23,887.00 |
| Dec 31, 2025 | -23,887.00 |
| Sep 30, 2025 | 21,578.00 |
| Sep 30, 2025 | 21,578.00 |
| Jun 30, 2025 | -7,590.00 |
| Jun 30, 2025 | -7,590.00 |
| Mar 31, 2025 | -4,924.00 |
| Mar 31, 2025 | -4,924.00 |
| Dec 31, 2024 | 532,574.00 |
| Dec 31, 2024 | 532,574.00 |
| Sep 30, 2024 | -13,070.00 |
| Sep 30, 2024 | -13,070.00 |
| Jun 30, 2024 | -12,255.00 |
| Jun 30, 2024 | -12,255.00 |
| Mar 31, 2024 | -14,517.00 |
| Mar 31, 2024 | -14,517.00 |
| Dec 31, 2023 | 511,740.00 |
| Dec 31, 2023 | 511,740.00 |
| Sep 30, 2023 | 30,635.00 |
| Sep 30, 2023 | 30,635.00 |
| Jun 30, 2023 | -39,327.00 |
| Jun 30, 2023 | -39,327.00 |
| Mar 31, 2023 | 8,692.00 |
| Mar 31, 2023 | 8,692.00 |
| Dec 31, 2022 | -294,046.00 |
| Dec 31, 2022 | -294,046.00 |
| Sep 30, 2022 | 197,146.00 |
| Sep 30, 2022 | 197,146.00 |
| Jun 30, 2022 | -73,547.00 |
| Jun 30, 2022 | -73,547.00 |
| Dec 31, 2021 | 610,213.00 |
| Dec 31, 2021 | 610,213.00 |
| Sep 30, 2021 | -466,132.00 |
| Sep 30, 2021 | -466,132.00 |
| Jun 30, 2021 | 75,734.00 |
| Jun 30, 2021 | 75,734.00 |
| Mar 31, 2021 | 296,025.00 |
| Mar 31, 2021 | 296,025.00 |
| Dec 31, 2020 | 5,506.00 |
| Dec 31, 2020 | 5,506.00 |
| Sep 30, 2020 | -6,171.00 |
| Sep 30, 2020 | -6,171.00 |
| Jun 30, 2020 | 606,120.00 |
| Jun 30, 2020 | 606,120.00 |
| Mar 31, 2020 | 101,498.00 |
| Mar 31, 2020 | 101,498.00 |
| Dec 31, 2018 | -5.00 |
| Dec 31, 2018 | -5.00 |